Insider filing · MDGL
Richard S Levy
Director
profile →
Madrigal Pharmaceuticals, Inc.
MDGL · Healthcare · 59 filings in 24 months
ticker →
Richard S Levy sold $4.2M of Madrigal Pharmaceuticals (MDGL)
Executed Nov 13 2025, disclosed Nov 14 2025, 1 day later.
Value, as filed
$4.2M
8,041 sh across 10 lots
Executed
Nov 13 2025
the trade date, as filed
Disclosed
Nov 14 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RLRichard S Levy (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Madrigal Pharmaceuticals, Inc. (MDGL). The largest single filing was $4.2M of MDGL (8,041 sh across 10 lots, as filed), executed Nov 13 2025.
The name
MDGLHealthcare · Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Richard S Levy in MDGL
MDGLSALE
Madrigal Pharmaceuticals, Inc.
$2.8M5,371 sh across 8 lots
Exec May 22
Filed May 22 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $1.8M
5,000 sh × $350.00
Exec Nov 7 2024
Filed Nov 8 2024 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $1.4M
4,700 sh across 3 lots
Exec Nov 1 2024
Filed Nov 5 2024 · 5:30 PM ET